Rising Incidence Of Hospital-Acquired Infections Fuels Growth In Hospital Acquired Infections Testing Kits Market: Critical Driver Shaping the Hospital Acquired Infections Testing Kits Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Hospital Acquired Infections Testing Kits Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for kits testing hospital-acquired infections has seen substantial growth in the recent past. The market, currently valued at $4.54 billion in 2024, is projected to expand to $4.83 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.4%. The historic growth in this market is largely due to the rise in hospital-acquired infection rates (HAIs), a growing aging population, and an increased number of surgeries.

Hospital Acquired Infections Testing Kits Market Size Forecast: What's the Projected Valuation by 2029?
There is an anticipated robust expansion in the market size of hospital acquired infections testing kits in the imminent years, reaching a size of $6.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. This growth during the forecast period can be credited to the prevalence of chronic illnesses, enhanced healthcare spending, and increased governmental backing. Key trends during this period consist of collaborations with artificial intelligence firms, availing governmental assistance, integrating big data into market evaluations, and forming partnerships with other market participants.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hospital-acquired-infections-testing-kits-global-market-report

What Are the Drivers Transforming the Hospital Acquired Infections Testing Kits Market?
There's an increasing prevalence of infections contracted within healthcare facilities, which are impacting both patients admitted into the hospital and those who are outpatients. These conditions, also known as nosocomial infections, are typically acquired within hospitals or clinics. To illustrate, data from the Center for Disease Control and Prevention reveals that approximately 1.7 million individuals in the United States contract these hospital-borne infections while they're being treated for other health problems, and an alarming figure of more than 98,000 (roughly 5%) succumb to these infections. Consequently, the growing occurrence of these hospital-acquired infections escalates the demand for test kits specific to diagnosing these infections in the market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2469&type=smp

What Long-Term Trends Will Define the Future of the Hospital Acquired Infections Testing Kits Market?
Technologies for diagnostic tests used in the identification of HAIs, including flow cytometry, mass spectrometry, near-infrared spectroscopy, and nucleic acid-based technologies are continually making advancements, yielding more precise data. Mass spectrometers have witnessed notable progression, permitting quantification of identified materials and detection of unknown compounds in a sample. For example, the X500 QTOF by SCIEX resolves the issue of contamination and, despite its compact size, does not sacrifice resolution or accuracy. It delivers results more quickly, enabling the user to make decisions based on the data sooner.

Which Segments in the Hospital Acquired Infections Testing Kits Market Offer the Most Profit Potential?
The hospital acquired infections testing kits market covered in this report is segmented -

1) By Product: Consumables And Reagents, Instruments
2) By Test Type: Pneumoia Infection, Urinary Track Infection, Blood Stream Associated Infection, Surgical Site Infection, MRSA infection, Others
3) By Pathogen Type: Viral, Bacterial, Fungal
4) By Application: Drug Resistance Testing, Disease Testing

Subsegments:
1) By Consumables and Reagents: Culture Media (Used for isolating and identifying pathogens), Reagents For Molecular Testing (Includes PCR reagents and kits for detecting specific pathogens), Test Kits (Rapid tests and other kits designed for various infections), Other Consumables (Includes swabs, sample collection devices, and preservation solutions)
2) By Instruments: Automated Analyzers (Equipment used for blood culture analysis and identification of pathogens), Molecular Diagnostic Instruments (Machines used for PCR and other molecular testing methods), Microscopes (Used for the identification of pathogens in samples), Incubators And Growth Chambers (For culturing samples under controlled conditions)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2469&type=smp

Which Firms Dominate the Hospital Acquired Infections Testing Kits Market by Market Share and Revenue in 2025?
Major companies operating in the hospital acquired infections testing kits market include Becton, Dickinson and Company, Abbott Laboratories, Cepheid, F. Hoffmann-La Roche Ltd, Hologic, Inc, STERIS plc, QIAGEN, Meridian Bioscience Inc., BioMérieux SA, Metall Zug (Belimed Group), Innovaccer, JD Health, CISCO Systems Inc, GE Healthcare, Honeywell Lifesciences, Zydus Cadila, ImmunoScience, CPC Diagnostics, Seegene, SD Biosensor, Vivacheck Lab, Fujirebio, Sysmex Corporation, Philip Healthcare, Getein Biotech, Hangzhou Biotest Biotech, AmonMed Biotechnology, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Bayer AG, Cantel Medical Corporation, Siemens Healthineers

Which Regions Offer the Highest Growth Potential in the Hospital Acquired Infections Testing Kits Market?
North America was the largest region in the hospital-acquired infections testing kits market in 2024. Western Europe was the second largest region in the global hospital-acquired infections testing kits market share. The regions covered in the hospital acquired infections testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2469

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.